Showing results (201-210 of 396) with videos related to

Sort By:
Pageof 40
Leukemia|November 1, 1995
Blast cell proliferative activity and sensitivity to GM-CSF in vitro are associated with early response to TAD-9 induction therapy in acute myeloid leukemiaG Jahns-Streubel, C Reuter, M Unterhalt, et al.
Journal of Chromatography|May 5, 1993
Column-switching solid-phase trace-enrichment high-performance liquid chromatographic method for measurement of buprenorphine and norbuprenorphine in human plasma and urine by electrochemical detectionE Schleyer, R Lohmann, C Rolf, et al.
Cancer Chemotherapy and Pharmacology|February 9, 2000
Impact of the simultaneous administration of the (+)- and (-)-forms of formyl-tetrahydrofolic acid on plasma and intracellular pharmacokinetics of (-)-tetrahydrofolic acidE Schleyer, K L Rudolph, J Braess, et al.
Anti-Cancer Drugs|February 1, 1995
Reversal of multiple drug resistance in vitro by phosphorothioate oligonucleotides and ribozymesJ Bertram, K Palfner, M Killian, et al.
Biochimica Et Biophysica Acta|October 6, 2000
Chromosomal organization and localization of the human histone deacetylase 5 gene (HDAC5)U Mahlknecht, S Schnittger, O G Ottmann, et al.
Annals of Hematology|August 20, 2002
Soluble tumor necrosis factor receptor type II in the early diagnosis of fever in neutropeniaM Goetz, G Behre, G Heussel, et al.
Annals of Hematology|July 1, 1997
Management of infections during intensive treatment of hematologic malignanciesG Maschmeyer, W Hiddemann, H Link, et al.
Cancer Treatment Reviews|September 1, 1990
High-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia--preliminary clinical and pharmacological data of a randomized comparisonW Hiddemann, E Schleyer, C Uhrmeister, et al.
Leukemia|February 16, 2000
Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy: relevance of cytogenetic abnormalitiesW Kern, C Schoch, T Haferlach, et al.
International Journal of Cancer|November 10, 2000
Adoptive transfer of human natural killer cells in mice with severe combined immunodeficiency inhibits growth of Hsp70-expressing tumorsG Multhoff, K Pfister, C Botzler, et al.
Pageof 40